Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231.
about
Biomarkers of Alzheimer's diseasePin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's diseaseThe role of biomarkers in clinical trials for Alzheimer diseaseTotal and phosphorylated tau protein as biological markers of Alzheimer's disease.Hyperphosphorylation and cleavage at D421 enhance tau secretionDysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic targetCSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy.Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay.Evidence from biomarkers and surrogate endpoints.Proteomic analysis of protein phosphorylation and ubiquitination in Alzheimer's disease.Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease.Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseasesBiomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia.
P2860
Q24650667-4F92BB5D-F4B0-4EF5-A495-B16E3DCA608CQ24684898-19627CEA-E0F0-4239-BFB3-2DF45829598CQ28085108-D46429F1-3732-4A62-9B92-F3B6A3B5B390Q31032781-052DBFD3-3173-4204-BEE7-75609A77449EQ33624674-14902A5D-BBBF-4A4A-A07A-AFA6F028DA5BQ34277477-40004F0B-BD80-4BB3-86FF-B0076CA5A3A2Q35016882-3F8EB528-3BC8-48B1-A478-6110E68E0F56Q35114771-F4A01D39-7EC2-4AA5-995B-24B6B1EB17EEQ35788903-0C092DC1-E8A8-401B-BF73-01C912A6ED05Q36045330-3FAA71BB-E9F7-47FA-8B27-5431594628AEQ36451474-5538A8C3-F318-4A0F-951D-A3C97BA7E861Q36696324-7803F5E9-0F39-4A5C-A65F-2835E4E23989Q36974613-AFA1D4DF-6197-493C-A78B-8CC52B365B2EQ37358672-0BBB744A-BF4F-4CAD-8D1D-DEAED229E42EQ42126269-918B949B-20F6-4E62-9C79-6C96AA5FDD75Q49905766-0A170712-4444-44E6-9E01-7BFF10CAA2E2
P2860
Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Tracking of Alzheimer's diseas ...... osphorylated at threonine 231.
@en
Tracking of Alzheimer's diseas ...... osphorylated at threonine 231.
@nl
type
label
Tracking of Alzheimer's diseas ...... osphorylated at threonine 231.
@en
Tracking of Alzheimer's diseas ...... osphorylated at threonine 231.
@nl
prefLabel
Tracking of Alzheimer's diseas ...... osphorylated at threonine 231.
@en
Tracking of Alzheimer's diseas ...... osphorylated at threonine 231.
@nl
P2093
P921
P356
P1433
P1476
Tracking of Alzheimer's diseas ...... osphorylated at threonine 231.
@en
P2093
P304
P356
10.1002/ANA.111.ABS
P577
2001-04-01T00:00:00Z